Decoding the Future: Newborn Screening Market on the Rise | Projected to Reach $2.0 Billion by 2031

Newborn screening identifies conditions that can affect a child's long-term health or survival. This screening technology includes a series of tests essential for timely detection, early diagnosis, and health management to prevent overall disability and avert death of a child. These tests are performed shortly after the baby is born, and detect genetic, developmental, and metabolic disorders in newborn babies. The global newborn screening market was valued at $1.1 billion in 2021, and is projected to reach $2.0 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/request-sample/1049

𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗜𝗺𝗽𝗮𝗰𝘁 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 (𝗣𝗿𝗲 & 𝗣𝗼𝘀𝘁) -

• The Covid-19 pandemic had a negative impact on the newborn screening market, as the majority of the screening centers experienced a broad spectrum of difficulties and most were affected during the pandemic.
• Availability of laboratory equipment and reagents was also delayed due to postal delays and unreliability, as well as flight cancellation.

The blood sample is screened for a variety of conditions, including but not limited to:

• Phenylketnuria (PKU)
• Hypothyroidism
• Galactosemia
• Sickle cell disease
• Cystic fibrosis
• Maple syrup urine disease
• Congenital adrenal hyperplasia
• Biotinidase deficiency

If the screening test indicates that the baby may have a condition, further testing is usually needed to confirm the diagnosis. If the diagnosis is confirmed, treatment can begin as soon as possible to prevent or minimize the risk of complications.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟐𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @
https://www.alliedmarketresearch.com/checkout-final/6939a226ebd5f396def6baae3ae0e64b

𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲 -

• Ge Healthcare,
• Trivitron Healthcare,
• Bio-Rad Laboratories Inc.,
• Covidien Plc,
• Natus Medical Incorporated,
• Ab Sciex LLC,
• Waters Corporation,
• MASIMO CORPORATION,
• Agilent Technologies Inc.,
• PERKINELMER, INC.

Newborn screening is a routine part of healthcare in many countries and is generally considered to be safe and effective. Early detection and treatment can help prevent serious health problems and improve outcomes for infants with these conditions. It's important to note that newborn screening is not a diagnosis and further testing may be required to confirm or rule out a condition.

𝗞𝗲𝘆 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀 𝗼𝗳 𝗧𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 -

• Based on product, the consumables held the largest market share in 2021 and is expected to remain dominant during the forecast period.
• Based on test, the blood test segment held the largest share in the global market in 2021
• On the basis of technology, the tandem mass spectrometry (TMS) held the largest market share in 2021 and is expected to remain dominant during the forecast period.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/1049

𝗚𝗲𝗼𝗴𝗿𝗮𝗽𝗵𝗶𝗰 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 -

The Newborn Screening Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)

• Europe (UK, Germany, France and the rest of Europe)

• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

• Latin America (Brazil, Mexico, and the rest of Latin America)

• Middle East and Africa (GCC and rest of the Middle East and Africa)

𝗙𝗿𝗲𝗾𝘂𝗲𝗻𝘁𝗹𝘆 𝗔𝘀𝗸𝗲𝗱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀?

1. What is newborn screening and why is it important for infants?

2. What conditions are typically screened for during newborn screening tests?

3. How is newborn screening performed and what does the process entail?

4. What are the benefits of early detection through newborn screening?

5. Are newborn screening tests mandatory, and are there any risks or limitations associated with them?

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀 -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.